Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus
about
Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule.Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.Positively Selected Sites at HCMV gB Furin Processing Region and Their Effects in Cleavage Efficiency.Human cytomegalovirus induces TGF-β1 activation in renal tubular epithelial cells after epithelial-to-mesenchymal transition.Characterization of a panel of insertion mutants in human cytomegalovirus glycoprotein B.Complex formation by human cytomegalovirus glycoproteins M (gpUL100) and N (gpUL73).An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membraneA continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus.Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblastsIdentification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.Identification of glycoprotein gpTRL10 as a structural component of human cytomegalovirusHuman cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H.Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.The human cytomegalovirus UL37 immediate-early regulatory protein is an integral membrane N-glycoprotein which traffics through the endoplasmic reticulum and Golgi apparatusGlycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex.The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infectionThe N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulates both B- and T-cell immune responses in humans.Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus.The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specificExpression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigenMultimerization of tegument protein pp28 within the assembly compartment is required for cytoplasmic envelopment of human cytomegalovirusProcessing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody responseCharacterization of envelope proteins of alcelaphine herpesvirus 1.Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB)Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirusCharacterization of herpesvirus sylvilagus glycoproteins released into the culture medium of infected cells: antisera to gp13 and gp32 neutralize viral infectivity in vitro and identify antigens on plasma membranes of infected cellsFunctional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope proteinCalnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.Molecular biology and immunology of cytomegalovirusReceptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B.Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblastsDisulfide bond configuration of human cytomegalovirus glycoprotein B.The human cytomegalovirus UL35 gene encodes two proteins with different functions.The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro.Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne.Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex.In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection.
P2860
Q31035724-0A5D9BC7-B7BE-4C33-8C43-9D0F91DD23D5Q33707484-9B0C6006-6691-452B-A296-800F8D47EB48Q33717651-F348EECC-1826-4216-8937-67F3DADBA896Q33747809-949E757C-D627-4520-88A0-157D8A53731EQ33793463-E1C89EB3-AB75-4442-929A-3A57D997CE01Q33813085-453DE137-BDB2-47B0-8F14-E82004186EBBQ33820909-AC546EA4-E712-41EF-9DEB-8D112D668CE1Q33935010-5EB2B8F4-AAA0-4E38-8E30-85EA12CC9E3AQ33987451-111255AB-6EFC-49A5-B1CE-0CB728618574Q34162769-EDDEF8B4-0C35-4F82-83C0-B3F5BF237E68Q34328645-33655586-8BCB-42B8-BDB5-CD1F2D61955BQ35847453-DEA7C3D4-1F8E-4B3D-B128-86EBE072517BQ35850918-C64456A0-C5A0-4360-AA3A-6CC18485D7F6Q35870987-AD3E9EAB-51B3-4B5C-BEA7-705DC7643440Q35881192-43C33F67-3701-4FFF-8813-256144FA2E06Q35887796-02B283BB-9274-4725-A9B6-3BD4C6BC4E8BQ36683070-C198BBAA-60CF-45D2-A7E5-18F28A616E75Q36685373-F9DE4500-212D-4367-8F2F-CF995F5C6906Q36687838-BA7C4BA4-FE68-4794-B59F-A915BB317BD0Q36691252-FCFAD092-3D86-4DCA-8FBC-6FE19D4D92B1Q36699001-70649A60-84CA-4649-9EDC-14F1FA7C6780Q36747999-22775D07-1A87-4DE2-8AC3-16D0C90D4227Q36780341-3F8523E9-E7D8-47DE-8789-8A98AFEEA25AQ36802016-3D9FB0BF-FE1A-4AB2-BAD1-ED58933296B7Q36810491-BFF82309-B4A5-4E02-A466-92F4386C7C21Q36827278-B9FDD3BA-052A-4D5E-B6FA-ADEA52863CC9Q36872453-3FFB707E-5C19-4E67-95A7-E98145FAD542Q36876105-C8DE8BBB-A1B1-4884-961C-802CE4678485Q36919666-551947D4-2ACD-4D33-8044-FB44EDFA7D95Q37519151-BA1C3468-7964-45E5-A70D-E4ACDF1D320BQ38359718-C9A42D17-1219-414D-9947-B6A39332B29AQ39509644-464297A9-FBF1-418E-A506-D593C08BBF4CQ39577652-67217AFF-236F-4649-B3D1-73965BDCCBBBQ39579432-5D564BC3-5C13-40AE-9234-54B17B67785DQ39683804-9A5A6883-ABAF-4A27-9830-13C2D15B44B5Q39748059-C25C456D-0786-4866-A23A-1B315B786895Q40060796-BCEE1712-4E4C-4CDB-A9F1-CA1438AEA542Q40109322-EB417C87-F683-449F-A316-F4F3A848ADC5Q40130953-866F8A1A-47A5-455D-A332-93DC273DFA6FQ40883283-07191B99-F1BD-4600-92DB-B91C7CE51338
P2860
Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus
@en
type
label
Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus
@en
prefLabel
Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus
@en
P2860
P1433
P1476
Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus
@en
P2093
P2860
P304
P407
P577
1986-04-01T00:00:00Z